CRYO CELL INTERNATIONAL INCCCELEarnings & Financial Report
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
Revenue
$8.0M
Gross Profit
$6.0M
Operating Profit
$1.4M
Net Profit
$655.8K
Gross Margin
74.8%
Operating Margin
17.3%
Net Margin
8.2%
YoY Growth
3.5%
EPS
$0.08
Financial Flow
CRYO CELL INTERNATIONAL INC Q2 2024 Financial Summary
CRYO CELL INTERNATIONAL INC reported revenue of $8.0M (up 3.5% YoY) for Q2 2024, with a net profit of $655.8K (up 196.8% YoY) (8.2% margin). Cost of goods sold was $2.0M, operating expenses totaled $4.6M.
Key Financial Metrics
| Total Revenue | $8.0M |
|---|---|
| Net Profit | $655.8K |
| Gross Margin | 74.8% |
| Operating Margin | 17.3% |
| Report Period | Q2 2024 |
CRYO CELL INTERNATIONAL INC Annual Revenue by Year
CRYO CELL INTERNATIONAL INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $31.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $31.6M |
| 2024 | $32.0M |
| 2023 | $31.3M |
| 2022 | $30.3M |
CRYO CELL INTERNATIONAL INC Quarterly Revenue & Net Profit History
CRYO CELL INTERNATIONAL INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $7.8M | -2.3% | $-3.8M | -48.7% |
| Q3 2025 | $7.8M | -3.0% | $749.4K | 9.6% |
| Q2 2025 | $7.9M | -1.4% | $355.8K | 4.5% |
| Q1 2025 | $8.0M | +1.5% | $282.9K | 3.5% |
| Q4 2024 | $8.0M | +1.9% | $-1.9M | -23.2% |
| Q3 2024 | $8.1M | +2.5% | $1.1M | 13.0% |
| Q2 2024 | $8.0M | +3.5% | $655.8K | 8.2% |
| Q1 2024 | $7.9M | +0.4% | $556.2K | 7.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9M | $8.0M | $8.1M | $8.0M | $8.0M | $7.9M | $7.8M | $7.8M |
| YoY Growth | 0.4% | 3.5% | 2.5% | 1.9% | 1.5% | -1.4% | -3.0% | -2.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $61.7M | $62.6M | $62.9M | $64.7M | $64.4M | $64.4M | $63.2M | $61.7M |
| Liabilities | $72.0M | $73.3M | $72.5M | $77.9M | $79.0M | $80.0M | $78.0M | $80.3M |
| Equity | $-10.3M | $-10.7M | $-9.6M | $-13.2M | $-14.7M | $-15.6M | $-14.8M | $-18.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-356865 | $1.8M | $2.4M | $2.2M | $954063 | $707014 | $2.5M | $1.3M |